OBJECTIVES: We studied the effect of body mass index (BMI) at peritoneal dialysis (PD) initiation on patient and technique survival and on peritonitis during follow-up. METHODS: We followed 328 incident patients on PD (176 with diabetes; 242 men; mean age: 52.6 ± 12.6 years; mean BMI: 21.9 ± 3.8 kg/m(2)) for 20.0 ± 14.3 months. Patients were categorized into four BMI groups: obese, ≥ 25 kg/m(2); overweight, 23 - 24.9 kg/m(2); normal, 18.5 - 22.9 kg/m(2) (reference category); and underweight, <18.5 kg/m(2). The outcomes of interest were compared between the groups. RESULTS: Of the 328 patients, 47 (14.3%) were underweight, 171 (52.1%) were normal weight, 53 (16.2%) were overweight, and 57 (17.4%) were obese at commencement of PD therapy. The crude hazard ratio (HR) for mortality (p = 0.004) and the HR adjusted for age, subjective global assessment, comorbidities, albumin, diabetes, and residual glomerular filtration rate (p = 0.02) were both significantly greater in the underweight group than in the normal-weight group. In comparison with the reference category, the HR for mortality was significantly greater for underweight PD patients with diabetes [2.7; 95% confidence interval (CI): 1.5 to 5.0; p = 0.002], but similar for all BMI categories of nondiabetic PD patients. Median patient survival was statistically inferior in underweight patients than in patients having a normal BMI. Median patient survival in underweight, normal, overweight, and obese patients was, respectively, 26 patient-months (95% CI: 20.9 to 31.0 patient-months), 50 patient-months (95% CI: 33.6 to 66.4 patient-months), 57.7 patient-months (95% CI: 33.2 to 82.2 patient-months), and 49 patient-months (95% CI: 18.4 to 79.6 patient-months; p = 0.015). Death-censored technique survival was statistically similar in all BMI categories. In comparison with the reference category, the odds ratio for peritonitis occurrence was 1.8 (95% CI: 0.9 to 3.4; p = 0.086) for underweight patients; 1.7 (95% CI: 0.9 to 3.2; p = 0.091) for overweight patients; and 3.4 (95% CI: 1.8 to 6.4; p < 0.001) for obese patients. CONCLUSIONS: In our PD patients, mean BMI was within the normal range. The HR for mortality was significantly greater for underweight diabetic PD patients than for patients in the reference category. Death-censored technique survival was similar in all BMI categories. Obese patients had a greater risk of peritonitis.
OBJECTIVES: We studied the effect of body mass index (BMI) at peritoneal dialysis (PD) initiation on patient and technique survival and on peritonitis during follow-up. METHODS: We followed 328 incident patients on PD (176 with diabetes; 242 men; mean age: 52.6 ± 12.6 years; mean BMI: 21.9 ± 3.8 kg/m(2)) for 20.0 ± 14.3 months. Patients were categorized into four BMI groups: obese, ≥ 25 kg/m(2); overweight, 23 - 24.9 kg/m(2); normal, 18.5 - 22.9 kg/m(2) (reference category); and underweight, <18.5 kg/m(2). The outcomes of interest were compared between the groups. RESULTS: Of the 328 patients, 47 (14.3%) were underweight, 171 (52.1%) were normal weight, 53 (16.2%) were overweight, and 57 (17.4%) were obese at commencement of PD therapy. The crude hazard ratio (HR) for mortality (p = 0.004) and the HR adjusted for age, subjective global assessment, comorbidities, albumin, diabetes, and residual glomerular filtration rate (p = 0.02) were both significantly greater in the underweight group than in the normal-weight group. In comparison with the reference category, the HR for mortality was significantly greater for underweight PDpatients with diabetes [2.7; 95% confidence interval (CI): 1.5 to 5.0; p = 0.002], but similar for all BMI categories of nondiabetic PDpatients. Median patient survival was statistically inferior in underweight patients than in patients having a normal BMI. Median patient survival in underweight, normal, overweight, and obesepatients was, respectively, 26 patient-months (95% CI: 20.9 to 31.0 patient-months), 50 patient-months (95% CI: 33.6 to 66.4 patient-months), 57.7 patient-months (95% CI: 33.2 to 82.2 patient-months), and 49 patient-months (95% CI: 18.4 to 79.6 patient-months; p = 0.015). Death-censored technique survival was statistically similar in all BMI categories. In comparison with the reference category, the odds ratio for peritonitis occurrence was 1.8 (95% CI: 0.9 to 3.4; p = 0.086) for underweight patients; 1.7 (95% CI: 0.9 to 3.2; p = 0.091) for overweight patients; and 3.4 (95% CI: 1.8 to 6.4; p < 0.001) for obesepatients. CONCLUSIONS: In our PDpatients, mean BMI was within the normal range. The HR for mortality was significantly greater for underweight diabetic PDpatients than for patients in the reference category. Death-censored technique survival was similar in all BMI categories. Obesepatients had a greater risk of peritonitis.
Authors: M Thamer; W Hwang; N E Fink; J H Sadler; S Wills; N W Levin; E B Bass; A S Levey; R Brookmeyer; N R Powe Journal: Am J Kidney Dis Date: 2000-12 Impact factor: 8.860
Authors: Joanna R Ghali; Kym M Bannister; Fiona G Brown; Johan B Rosman; Kathryn J Wiggins; David W Johnson; Stephen P McDonald Journal: Perit Dial Int Date: 2011-06-30 Impact factor: 1.756
Authors: D W Johnson; K A Herzig; D M Purdie; W Chang; A M Brown; R J Rigby; S B Campbell; D L Nicol; C M Hawley Journal: Perit Dial Int Date: 2000 Nov-Dec Impact factor: 1.756
Authors: Monika A Krezalek; Nicolas Bonamici; Kristine Kuchta; Brittany Lapin; JoAnn Carbray; Woody Denham; John Linn; Michael Ujiki; Stephen P Haggerty Journal: Surg Endosc Date: 2017-09-15 Impact factor: 4.584
Authors: Annie-Claire Nadeau-Fredette; Carmel Hawley; Elaine Pascoe; Christopher T Chan; Martine Leblanc; Philip A Clayton; Kevan R Polkinghorne; Neil Boudville; David W Johnson Journal: Perit Dial Int Date: 2015-11-02 Impact factor: 1.756